FDA Approval of Andexanet Alfa Based on a Single-Arm Trial: If There Is a Villain, Who Is It?
Ann Emerg Med
.
2019 Nov;74(5):725-727.
doi: 10.1016/j.annemergmed.2019.05.034.
Author
Daniel J Pallin
1
Affiliation
1
Cambridge, MA.
PMID:
31668248
DOI:
10.1016/j.annemergmed.2019.05.034
No abstract available
Publication types
Letter
Comment
MeSH terms
Factor Xa Inhibitors*
Factor Xa*
Hemorrhage
Humans
Recombinant Proteins
Substances
Factor Xa Inhibitors
PRT064445
Recombinant Proteins
Factor Xa